rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ryan Preblick

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Indivior Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
18
Buys
0
Sells
1
Bought
$0
Sold
$2.7M
Companies
1
Companies where not an officer
0
First trade
9 Feb 2026
Last trade
8 Jun 2026
Last filed
10 Jun 2026

Companies traded

Where they are an officer
INDV Indivior PharmaceuticalsOfficer · Pharmaceuticals · last 8 Jun 20260 buys · 1 sell

Activity over time

1 Jun – 1 Oct
10Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 10 Jun 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$1.4M36,000 at $37.70filing
8 Jun 2026filed 10 Jun 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$1.4M36,000 at $37.70filing
14 Mar 2026filed 17 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—6,302filing
14 Mar 2026filed 17 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$88K2,843 at $31.11filing
14 Mar 2026filed 17 Mar 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,302filing
14 Mar 2026filed 17 Mar 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,302filing
14 Mar 2026filed 17 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—6,302filing
14 Mar 2026filed 17 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$88K2,843 at $31.11filing
3 Mar 2026filed 5 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$2.8M87,597 at $31.98filing
3 Mar 2026filed 5 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—86,949filing
3 Mar 2026filed 5 Mar 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—113,510filing
3 Mar 2026filed 5 Mar 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—113,510filing
3 Mar 2026filed 5 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$2.8M87,597 at $31.98filing
3 Mar 2026filed 5 Mar 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code M—86,949filing
10 Feb 2026filed 12 Feb 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—37,358 at $0.00filing
10 Feb 2026filed 12 Feb 2026INDV Indivior PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—37,358 at $0.00filing
9 Feb 2026filed 12 Feb 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—113,510 at $0.00filing
9 Feb 2026filed 12 Feb 2026INDV Indivior Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—113,510 at $0.00filing

News

Contrasting Orion OYJ (OTCMKTS:ORINY) & Indivior (NASDAQ:INDV)INDV · themarketsdaily.com · 19 Oct 2026

0 headlines in the last 90 days name Ryan Preblick; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Woodrow D. AndersonChief Accounting Officer · Chief Accounting Officer at Indivior Pharmaceuticals, filing Form 4 there in the last year
Christian HeidbrederChief Scientific Officer · Chief Scientific Officer at Indivior Pharmaceuticals, filing Form 4 there in the last year
Joseph CiaffoniChief Executive Officer · Chief Executive Officer at Indivior Pharmaceuticals, filing Form 4 there in the last year
Juliet ThompsonDirector · Director at Indivior Pharmaceuticals, filing Form 4 there in the last year
David E. WheadonDirector · Director at Indivior Pharmaceuticals, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded INDV in the last 90 days